Bio-Techne Corporation EBIT for the Trailing 12 Months (TTM) ending March 31, 2025: USD 202.55 M

Bio-Techne Corporation EBIT is USD 202.55 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -22.44% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Bio-Techne Corporation EBIT for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 261.16 M, a -5.00% change year over year.
  • Bio-Techne Corporation EBIT for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 274.92 M, a 18.99% change year over year.
  • Bio-Techne Corporation EBIT for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 231.05 M, a -3.26% change year over year.
  • Bio-Techne Corporation EBIT for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 238.84 M, a 63.60% change year over year.
Key Data
Date EBIT EBITDA Net Income EPS (Diluted)